Market Update (NYSE:ABBV): AbbVie, Teva broke law in AndroGel "pay for delay" deal, U.S. says

[Reuters] – The U.S. Federal Trade Commission on Monday sued Drugmakers AbbVie Inc and Teva Pharmaceuticals Industries Ltd for allegedly illegally preventing generic versions of AndroGel, for men with low testosterone, … Read . . . → Read More: Market Update (NYSE:ABBV): AbbVie, Teva broke law in AndroGel "pay for delay" deal, U.S. says Similar Articles: Stock Update (NYSE:ABBV): INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Firm Company Update: AbbVie Inc (NYSE:ABBV) – AbbVie to Present at 2014 UBS Global Healthcare Conference Market Update (NASDAQ:MSFT): Microsoft deal delay may mean more Nokia patent concessions